Changes in Revenue Recognition and Presentation Following Adoption of the Revenue Recognition Standard
First written in FY2022-Q1. 2 of 5 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the current consolidated fiscal year, the company identified an indication of impairment in an asset group in part of its pharmaceuticals, medical and healthcare business, consisting of ¥455 million in property, plant and equipment and other assets, because demand declined due to delays in the clinical development of a biotech venture caused by a delayed recovery in the US investment environment. However, no impairment loss was recognized because the total undiscounted future cash flows expected from the asset group exceeded its carrying amount.」
For certain defense-related transactions concerning revenue recognition, revenue was allocated over the relevant period according to the progress of performance obligations, and ¥11,767 million in revenue related to incomplete contracts for the current fiscal year was disclosed. - FY2022Full-Year Impact ConfirmedAnnual report
「As a result, for the current consolidated fiscal year, net sales decreased by ¥5,994 million and operating income increased by ¥309 million. There was no impact on ordinary income or net income before income taxes. The opening balance of retained earnings also increased by ¥73 million.」
The company disclosed the full-year impact of applying the revenue recognition accounting standard and other standards, with net sales down ¥5,994 million, operating income up ¥309 million and the opening balance of retained earnings up ¥73 million. - FY2022-Q3Cumulative impact updatedAnnual report
「As a result, for the cumulative third quarter of the current consolidated fiscal year, net sales decreased by ¥4,609 million and operating income increased by ¥166 million. There was no impact on ordinary income or quarterly net income before income taxes. The opening balance of retained earnings also increased by ¥73 million.」
The company updated the cumulative third-quarter impact of applying the revenue recognition accounting standard and other standards, disclosing a ¥4,609 million decrease in net sales, a ¥166 million increase in operating income and a ¥73 million increase in the opening balance of retained earnings. - FY2022-Q2AdvancedAnnual report
「As a result, for the cumulative second quarter of the current consolidated fiscal year, net sales decreased by ¥2,942 million and operating income increased by ¥108 million. There was no impact on ordinary income or quarterly net income before income taxes. The opening balance of retained earnings also increased by ¥73 million.」
The company disclosed the cumulative first-half impact of applying the revenue recognition accounting standard. Net sales decreased by ¥2,942 million, operating income increased by ¥108 million and the opening balance of retained earnings increased by ¥73 million. - FY2022-Q1First statedAnnual report
「The company has applied the Accounting Standard for Revenue Recognition and the Implementation Guidance on Accounting Standard for Revenue Recognition from the beginning of the first quarter of the current consolidated fiscal year. As a result, when the performance obligation represented by a promise to a customer is to arrange for goods or services to be provided by another party, the company recognizes revenue on a net basis as an agent. Consequently, for the cumulative first quarter of the current consolidated fiscal year, net sales decreased by ¥1,832 million and operating income increased by ¥59 million. The opening balance of retained earnings also increased by ¥73 million.」
The new standard was applied from the beginning of the first quarter, and transactions conducted as an agent were changed to net revenue recognition. The amounts of the impact on net sales, operating income and retained earnings were disclosed.